McCusick VAMendelian Inheritance in Man: Catalogs of Autosomal Dominant, Autosomal Recessive and X-linked Phenotypes. Baltimore, MD: Johns Hopkins Press; 1966:167.
2.
Halley Djj, Bijman J., deJonge HR, et al. The cystic fibrosis defect approached from different angles — new perspectives on the gene, the chloride channel, diagnosis and therapy . Eur J Pediatr.1990;149:670-677.
3.
Moran A., Diem P., Klein DJ, et al. Pancreatic endocrine function in cystic fibrosis. J Pediatr.1991;118:715-723.
4.
Cystic Fibrosis: A Disease in Search of Ideas . Bethesda, MD: National Institutes of Health; 1979. U.S. Dept. of Health , Education & Welfare publication no. 79-1643:33-34.
5.
Rodman HM, Doershuk CF, Roland JMThe interaction of 2 diseases: diabetes mellitus and cystic fibrosis . Medicine.1986;65:389-397.
6.
Reisman J., Corey M., Canny G., Levison H.Diabetes mellitus in patients with cystic fibrosis: effect on survival . Pediatrics. 1990;86:374-377.
7.
Finkelstein SM, Wielinski CL, Elliot GR, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr.1988;112:373-377.
8.
ImrieJR, Fagan DG, SturgessJMQuantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol.1979;95:697-708.
9.
Abdul-Karim FW, Dahms BB, Velasco ME, Rodman HMIslets of Langerhans in adolescents and adults with cystic fibrosis. Arch Pathol Lab Med.1986;110:602-606.
10.
Lohr M., Goertchen P., Nizze H., et al. Cystic fibrosis-associated islet changes may provide a basis for diabetes. Virchows Archiv [A].1989 ;414:179-185.
11.
Soejima K., Landing BHPancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol. 1986;6:25-46.
12.
lannucci A. , Mukai K., Johnson D., Burke B.Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol.1984 ;15:278-284.
13.
Gepts W.The pancreatic islets in diabetes. Am J Med.1981;70:105-115.
Rahier J., Goebbels RM, Henquin JCCellular composition of the human diabetic pancreas. Diabetologia . 1983;24:366-371.
16.
Gepts W.Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965;14:619-632.
17.
Kloppel G., Drenck CR, Oberholzer M., et al. Morphometric evidence for a striking beta-cell reduction at the clinical onset of type 1 diabetes. Virchows Arch [A].1984;403:441-452.
18.
Handwerger S., Roth J., Gorden P., et al. Glucose intolerance in cystic fibrosis . N Engl J Med.1969;281:451-461.
19.
Lippe BM, Sperling MA, Dooley RRPancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr.1977;90:751-755.
20.
Bistritzer T., Sack J., Eshkol A., Katznelson D.Hemoglobin A1 and pancreatic beta cell function in cystic fibrosis . Isr J Med Sci.1983;19:600-603.
21.
Geffner ME, Lippe BM, Kaplan SA, et al. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function. Pediatr Res.1984;18:1107-1111.
22.
Stahl M., Girard J., Rutishauser M., et al. Endocrine function of the pancreas in cystic fibrosis: evidence for an impaired glucagon and insulin response following arginine infusion . J Pediatr.1974;84:821-824.
23.
Geffner ME, Lippe BM, Itami RM, et al. Insulin resistance in a young man with cystic fibrosis. Am J Dis Child.1984;138:677-680.
24.
Ross SA, Morrison D., McArthur RGHypersecretion of gastric inhibitory polypeptide in non-diabetic children with cystic fibrosis. Pediatrics. 1981;67:252-254.
25.
Wilmshurst EG , Soeldner JS, Holsclaw DS, et al. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics. 1975;55:75-81.
26.
Dandona P., Hodson ME, Batten JGBeta-cell reserve in cystic fibrosis patients and heterozygotes. J Clin Pathol.1983;36:790-792.
27.
Lippe BM, Kaplan SA, Neufeld ND, et al. Insulin receptors in cystic fibrosis: increased receptor number and altered affinity. Pediatrics. 1980;65:1018-1022.
28.
Knowles MRDiabetes and cystic fibrosis: new questions emerging from increased longevity . J Pediatr.1988;112:415-416.
Sandler M.Can we predict and/or prevent type I diabetes? S Afr Med J.1990;78:462-467.
32.
Hitchcock CL , Riley WJ, Maclaren NKAutoimmunity in insulin-dependent diabetes mellitus: its detection and prevention . Concepts Immunopathol . 1988;5:144-167.
33.
Baekkeskov S., Aanstoot H-J., Christgau S., et al. Identification of the 64K autoantigen in insulin-dependent diabetes mellitus as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151-156.
34.
National Diabetes Data Group.Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes.1979;28:1039-1057.
35.
Geffner ME, Lippe BM, Maclaren NK, Riley WJRole of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis. J Pediatr.1988;112:419-421.
36.
Cucinotta D. , Conti-Nibali S., Arrigo T., et al. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res. 1990;34:33-38.
37.
Stutchfield PR, O'Halloron SM, Smith CS, et al. HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis. Arch Dis Child.1988;63:1234-1239.
38.
Schwarz HP, Bannard GD, Neri TM, et al. Histocompatibility antigens in patients with cystic fibrosis and diabetes mellitus. J Pediatr.1984;104:799-800.
39.
Miller ME, Baker L.Leucocyte function in juvenile diabetes mellitus: humoral and cellular aspects . J Pediatr.1972;81:979-982.
40.
Bagdade JD, Stewart M., Walters E.Impaired granulocyte adherence: a reversible defect in patients with poorly controlled diabetes. Diabetes. 1978 ;27:677-681.
41.
Davidson NJ , Sowder JM, Fletcher J.Defective phagocytosis in insulin-controlled diabetes: evidence for a reaction between glucose and opsonizing proteins . J Clin Pathol.1984;37:783-786.
42.
Rayfield EJ , Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control. Am J Med.1982 ;72:439-449.
43.
Dolan TFMicroangiopathy in a young adult with cystic fibrosis and diabetes mellitus . N Engl J Med.1986;314:991-992.
44.
Allen JLProgressive nephropathy in a patient with cystic fibrosis and diabetes mellitus . N Engl J Med.1986;315:764.
45.
Sullivan MM , Denning CRDiabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 1989;84:642-647.
46.
Rosenstein BJ, Eigen H.Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics. 1991 ;87:245-246.
47.
Stutchfield PR, O'Halloran S., Teale JD, et al. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child.1987;62:805-810.
48.
DeSchepper J., Dab I., Derde MP, Loeb H.Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations . Eur J Pediatr.1991;150:403-406.
49.
Zipf WB, Kien CL, Horswill CA, et al. Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis. Pediatr Res.1991;30:309-314.
50.
Sheehan JP, Ulchaker MM, Doerstruk CF, et al. Diet, cystic fibrosis, and diabetes: making friends with the perfect enemy. Lancet. 1990;336:501.